{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T19:27:46Z","timestamp":1787254066551,"version":"build-2736575974"},"reference-count":45,"publisher":"American Diabetes Association","issue":"9","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Diabetic kidney disease (DKD) remains the leading cause of end-stage renal disease worldwide, despite therapeutic advances. Podocyte injury constitutes a critical pathogenic process in DKD. This study elucidated the role of the neonatal Fc receptor (FcRn) in DKD-associated podocyte injury. In DKD, glomerular FcRn expression was markedly elevated and inversely correlated with podocin levels. In diabetic mice, podocyte-specific FcRn deficiency significantly ameliorated insulin resistance and mitigated podocyte damage. Mechanistically, FcRn upregulation in diabetic podocytes exacerbated insulin resistance, suppressed AKT\/mTOR signaling, and impaired autophagy, thereby promoting podocyte injury. These findings identify FcRn as a pivotal contributor to podocyte injury in DKD and suggest that FcRn targeting represents a promising therapeutic strategy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Article Highlights<\/jats:title>\n                    <jats:p>Neonatal Fc receptor (FcRn) mediates podocyte injury in immune complex nephropathies, but its role in diabetic kidney disease (DKD) remains undefined. This study demonstrates marked FcRn upregulation in DKD podocytes and elucidates the functional consequences of podocyte FcRn deficiency. FcRn deficiency protects podocytes in DKD by restoring autophagy via enhanced insulin sensitivity and subsequent AKT\/mTOR signaling activation. These findings identify FcRn as a novel therapeutic target for DKD, offering a strategy to mitigate the substantial residual risk of disease progression despite current therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/db26-0008","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T14:31:45Z","timestamp":1784730705000},"page":"1657-1672","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":0,"title":["FcRn Upregulation Exacerbates Podocyte Injury via Insulin Resistance\u2013Induced Autophagy Disorder in Diabetic Kidney Disease"],"prefix":"10.2337","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9318-3129","authenticated-orcid":false,"given":"Shaozheng","family":"Ai","sequence":"first","affiliation":[{"name":"Department of Nephrology, Clinic College of Medicine, Qinghai University Affiliated Hospital 1 , Xining, Qinghai Province, China"},{"name":"Clinical Research Center for Chronic Kidney Disease in Qinghai Province 2 , Xining, Qinghai Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlin","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Clinic College of Medicine, Qinghai University Affiliated Hospital 1 , Xining, Qinghai Province, China"},{"name":"Clinical Research Center for Chronic Kidney Disease in Qinghai Province 2 , Xining, Qinghai Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3565-8024","authenticated-orcid":false,"given":"Chun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Union Hospital Tongji Medical College Huazhong University of Science and Technology 3 , Wuhan, Hubei Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Beijing Hospital 4 , Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Clinic College of Medicine, Qinghai University Affiliated Hospital 1 , Xining, Qinghai Province, China"},{"name":"Clinical Research Center for Chronic Kidney Disease in Qinghai Province 2 , Xining, Qinghai Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Clinic College of Medicine, Qinghai University Affiliated Hospital 1 , Xining, Qinghai Province, China"},{"name":"Clinical Research Center for Chronic Kidney Disease in Qinghai Province 2 , Xining, Qinghai Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Clinic College of Medicine, Qinghai University Affiliated Hospital 1 , Xining, Qinghai Province, China"},{"name":"Clinical Research Center for Chronic Kidney Disease in Qinghai Province 2 , Xining, Qinghai Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Clinic College of Medicine, Qinghai University Affiliated Hospital 1 , Xining, Qinghai Province, China"},{"name":"Clinical Research Center for Chronic Kidney Disease in Qinghai Province 2 , Xining, Qinghai Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2271-2750","authenticated-orcid":false,"given":"Pengli","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Clinic College of Medicine, Qinghai University Affiliated Hospital 1 , Xining, Qinghai Province, China"},{"name":"Clinical Research Center for Chronic Kidney Disease in Qinghai Province 2 , Xining, Qinghai Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"2026082014522219500_B1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","author":"GBD Chronic Kidney Disease Collaboration","year":"2020","journal-title":"Lancet"},{"key":"2026082014522219500_B2","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.2337\/dci23-0030","article-title":"Diabetic nephropathy: update on pillars of therapy slowing progression","volume":"46","author":"Naaman","year":"2023","journal-title":"Diabetes Care"},{"key":"2026082014522219500_B3","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1053\/j.ajkd.2017.10.026","article-title":"Update on diabetic nephropathy: core curriculum 2018","volume":"71","author":"Umanath","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"2026082014522219500_B4","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.2337\/db18-0837","article-title":"Diabetes-induced DUSP4 reduction promotes podocyte dysfunction and progression of diabetic nephropathy","volume":"68","author":"Denhez","year":"2019","journal-title":"Diabetes"},{"key":"2026082014522219500_B5","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1681\/ASN.2010010010","article-title":"Pathologic classification of diabetic nephropathy","volume":"21","author":"Tervaert","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"2026082014522219500_B6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.kint.2022.05.012","article-title":"Molecular mechanisms and therapeutic targets for diabetic kidney disease","volume":"102","author":"Tuttle","year":"2022","journal-title":"Kidney Int"},{"key":"2026082014522219500_B7","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1681\/ASN.2018050490","article-title":"What is the glomerular ultrafiltration barrier?","volume":"29","author":"Fissell","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"2026082014522219500_B8","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.kint.2016.01.012","article-title":"Podocyte injury and its consequences","volume":"89","author":"Nagata","year":"2016","journal-title":"Kidney Int"},{"key":"2026082014522219500_B9","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41572-020-0196-7","article-title":"Podocytopathies","volume":"6","author":"Kopp","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"2026082014522219500_B10","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.kint.2020.04.036","article-title":"Interleukin-9 protects from early podocyte injury and progressive glomerulosclerosis in adriamycin-induced nephropathy","volume":"98","author":"Xiong","year":"2020","journal-title":"Kidney Int"},{"key":"2026082014522219500_B11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s40001-022-00779-9","article-title":"IgG subclass deposition in diabetic nephropathy","volume":"27","author":"Tang","year":"2022","journal-title":"Eur J Med Res"},{"key":"2026082014522219500_B12","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.diabres.2014.09.051","article-title":"Clinical implications of linear immunofluorescent staining for immunoglobulin G in patients with diabetic nephropathy","volume":"106","author":"Mise","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"2026082014522219500_B13","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/1753-0407.13024","article-title":"Implications of immunoglobulin G deposit in glomeruli in Chinese patients with diabetic nephropathy","volume":"12","author":"Zhang","year":"2020","journal-title":"J Diabetes"},{"key":"2026082014522219500_B14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41577-022-00821-1","article-title":"The therapeutic age of the neonatal Fc receptor","volume":"23","author":"Pyzik","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"2026082014522219500_B15","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1681\/ASN.2013050498","article-title":"Neonatal Fc receptor promotes immune complex-mediated glomerular disease","volume":"25","author":"Olaru","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"2026082014522219500_B16","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri2155","article-title":"FcRn: the neonatal Fc receptor comes of age","volume":"7","author":"Roopenian","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"2026082014522219500_B17","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.3389\/fimmu.2019.01540","article-title":"The neonatal Fc receptor (FcRn): a misnomer?","volume":"10","author":"Pyzik","year":"2019","journal-title":"Front Immunol"},{"key":"2026082014522219500_B18","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.cmet.2024.01.015","article-title":"IgG is an aging factor that drives adipose tissue fibrosis and metabolic decline","volume":"36","author":"Yu","year":"2024","journal-title":"Cell Metab"},{"key":"2026082014522219500_B19","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cmet.2024.11.001","article-title":"FcRn-dependent IgG accumulation in adipose tissue unmasks obesity pathophysiology","volume":"37","author":"Yu","year":"2025","journal-title":"Cell Metab"},{"key":"2026082014522219500_B20","doi-asserted-by":"crossref","first-page":"28406","DOI":"10.1021\/acsnano.4c11172","article-title":"Bioengineered nanomedicines targeting the intestinal Fc receptor achieve the improved glucoregulatory effect of semaglutide in a type 2 diabetic mice model","volume":"18","author":"Pinto","year":"2024","journal-title":"ACS Nano"},{"key":"2026082014522219500_B21","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1053\/j.ackd.2014.03.011","article-title":"Podocytes, signaling pathways, and vascular factors in diabetic kidney disease","volume":"21","author":"Brosius","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"key":"2026082014522219500_B22","doi-asserted-by":"crossref","first-page":"e0230401","DOI":"10.1371\/journal.pone.0230401","article-title":"Podocyte-specific knockout of the neonatal Fc receptor (FcRn) results in differential protection depending on the model of glomerulonephritis","volume":"15","author":"Dylewski","year":"2020","journal-title":"PLoS One"},{"key":"2026082014522219500_B23","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41574-021-00551-9","article-title":"Autophagy in metabolic disease and ageing","volume":"17","author":"Kitada","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"2026082014522219500_B24","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41392-022-01073-0","article-title":"Trends in insulin resistance: insights into mechanisms and therapeutic strategy","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"2026082014522219500_B25","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/MNH.0000000000000078","article-title":"Insulin signaling: implications for podocyte biology in diabetic kidney disease","volume":"24","author":"Coward","year":"2015","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2026082014522219500_B26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cmet.2010.08.015","article-title":"Insulin signaling to the glomerular podocyte is critical for normal kidney function","volume":"12","author":"Welsh","year":"2010","journal-title":"Cell Metab"},{"key":"2026082014522219500_B27","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/ki.2010.526","article-title":"Glomerular-specific protein kinase C-\u03b2-induced insulin receptor substrate-1 dysfunction and insulin resistance in rat models of diabetes and obesity","volume":"79","author":"Mima","year":"2011","journal-title":"Kidney Int"},{"key":"2026082014522219500_B28","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1046\/j.1523-1755.2002.00257.x","article-title":"Insulin is a potent survival factor in mesangial cells: role of the PI3-kinase\/Akt pathway","volume":"61","author":"Hiromura","year":"2002","journal-title":"Kidney Int"},{"key":"2026082014522219500_B29","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/ki.2008.109","article-title":"Failure to phosphorylate AKT in podocytes from mice with early diabetic nephropathy promotes cell death","volume":"73","author":"Tejada","year":"2008","journal-title":"Kidney Int"},{"key":"2026082014522219500_B30","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1007\/s00125-017-4394-0","article-title":"Prolonged exposure of mouse and human podocytes to insulin induces insulin resistance through lysosomal and proteasomal degradation of the insulin receptor","volume":"60","author":"Lay","year":"2017","journal-title":"Diabetologia"},{"key":"2026082014522219500_B31","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1038\/s41598-018-22233-9","article-title":"Enhanced insulin receptor, but not PI3K, signalling protects podocytes from ER stress","volume":"8","author":"Garner","year":"2018","journal-title":"Sci Rep"},{"key":"2026082014522219500_B32","doi-asserted-by":"crossref","first-page":"6496","DOI":"10.1038\/ncomms7496","article-title":"Defective podocyte insulin signalling through p85-XBP1 promotes ATF6-dependent maladaptive ER-stress response in diabetic nephropathy","volume":"10","author":"Madhusudhan","year":"2015","journal-title":"Nat Commun"},{"key":"2026082014522219500_B33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","article-title":"Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables","volume":"6","author":"Ahlqvist","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026082014522219500_B34","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3389\/fendo.2018.00693","article-title":"The evolving importance of insulin signaling in podocyte health and disease","volume":"9","author":"Lay","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026082014522219500_B35","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.2337\/dc13-0631","article-title":"Early diabetic nephropathy: a complication of reduced insulin sensitivity in type 1 diabetes","volume":"36","author":"Bjornstad","year":"2013","journal-title":"Diabetes Care"},{"key":"2026082014522219500_B36","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.2337\/db05-1484","article-title":"Insulin resistance and microalbuminuria: a cross-sectional, case-control study of 158 patients with type 2 diabetes and different degrees of urinary albumin excretion","volume":"55","author":"Parvanova","year":"2006","journal-title":"Diabetes"},{"key":"2026082014522219500_B37","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/s41588-021-00948-2","article-title":"Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes","volume":"53","author":"Mansour Aly","year":"2021","journal-title":"Nat Genet"},{"key":"2026082014522219500_B38","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1111\/ajt.15366","article-title":"The neonatal Fc receptor: key to homeostasic control of IgG and IgG-related biopharmaceuticals","volume":"19","author":"Baldwin","year":"2019","journal-title":"Am J Transplant"},{"key":"2026082014522219500_B39","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jaci.2020.07.016","article-title":"Targeting FcRn for immunomodulation: benefits, risks, and practical considerations","volume":"146","author":"Peter","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"2026082014522219500_B40","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41581-020-0309-2","article-title":"Autophagy in kidney homeostasis and disease","volume":"16","author":"Tang","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"2026082014522219500_B41","doi-asserted-by":"crossref","first-page":"154400","DOI":"10.1016\/j.phymed.2022.154400","article-title":"Paeoniflorin binds to VEGFR2 to restore autophagy and inhibit apoptosis for podocyte protection in diabetic kidney disease through PI3K-AKT signaling pathway","volume":"106","author":"Wang","year":"2022","journal-title":"Phytomedicine"},{"key":"2026082014522219500_B42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1681\/ASN.2004080648","article-title":"Mouse models of diabetic nephropathy","volume":"16","author":"Breyer","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"2026082014522219500_B43","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.mayocp.2019.08.026","article-title":"Sex differences in diabetic kidney disease","volume":"95","author":"Maric-Bilkan","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"2026082014522219500_B44","doi-asserted-by":"crossref","first-page":"14791641211058856","DOI":"10.1177\/14791641211058856","article-title":"Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: a review of the literature","volume":"18","author":"Thipsawat","year":"2021","journal-title":"Diab Vasc Dis Res"},{"key":"2026082014522219500_B45","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/ng1796","article-title":"Positional cloning of Sorcs1, a type 2 diabetes quantitative trait locus","volume":"38","author":"Clee","year":"2006","journal-title":"Nat Genet"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/75\/9\/1657\/889449\/db260008.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/75\/9\/1657\/889449\/db260008.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T18:52:36Z","timestamp":1787251956000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/75\/9\/1657\/172242\/FcRn-Upregulation-Exacerbates-Podocyte-Injury-via"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":45,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,7,22]]},"published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db26-0008","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]}}}